Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dornase Alfa vs Saline for LRTI Post Lung Transplant
NCT01952470Phase 2Completed
- Sponsor
- Alfred Health
- Start
- Oct 2013
- Primary completion
- Aug 2017
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of dornase alfa in lower respiratory tract infection (LRTI), sponsored by Alfred Health. Started Oct 2013; status: completed.
02
Drugs
dornase alfa
03
Conditions
lower respiratory tract infection (LRTI)
Beyond the preview
Go deeper on NCT01952470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01952470.